ArticleBMC cancer2019

Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting.

Molly J Carroll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.